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Abstract
Legionella pneumophila (L. pneumophila), the causative agent of a severe form of pneumonia called Legionnaires’ disease,
replicates in human monocytes and macrophages. Most inbred mouse strains are restrictive to L. pneumophila infection
except for the A/J, Nlrc4
2/2 (Ipaf
2/2), and caspase-1
2/2 derived macrophages. Particularly, caspase-1 activation is detected
during L. pneumophila infection of murine macrophages while absent in human cells. Recent in vitro experiments
demonstrate that caspase-7 is cleaved by caspase-1. However, the biological role for caspase-7 activation downstream of
caspase-1 is not known. Furthermore, whether this reaction is pertinent to the apoptosis or to the inflammation pathway or
whether it mediates a yet unidentified effect is unclear. Using the intracellular pathogen L. pneumophila, we show that,
upon infection of murine macrophages, caspase-7 was activated downstream of the Nlrc4 inflammasome and required
caspase-1 activation. Such activation of caspase-7 was mediated by flagellin and required a functional Naip5. Remarkably,
mice lacking caspase-7 and its macrophages allowed substantial L. pneumophila replication. Permissiveness of caspase-7
2/2
macrophages to the intracellular pathogen was due to defective delivery of the organism to the lysosome and to delayed
cell death during early stages of infection. These results reveal a new mechanism for caspase-7 activation downstream of
the Nlrc4 inflammasome and present a novel biological role for caspase-7 in host defense against an intracellular bacterium.
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Introduction
Caspases are a family of cysteine proteases expressed as inactive
pro-enzymes that play a central role in most cell death pathways
leading to apoptosis. However, growing evidence implicates
caspases in non-apoptotic functions [1–4]. Eleven genes were found
in the human genome to encode 11 human caspases, whereas 10
genes were found in the mouse genome to encode 10 murine
caspases. The human caspase-4 and -5 are functional orthologs of
mouse caspase-11 and -12. The remaining caspases which share
same nomenclature in human and mouse are functional orthologs
of each other [1]. On the basis of their biological functions, caspases
can be classified into three groups: inflammatory caspases like
caspase-1, -4, -5,-11and -12, initiatorcaspases like caspase-2, -8,-9,
and -10, and effector caspases like caspase-3, -6, -7 and -14 [2,4].
Caspase-1 activation mediates the maturation of the proinflamma-
tory cytokines interleukin-1 beta (IL-1b), IL-18 and possibly IL-33
[5,6]. Activation of caspase-1 is mediated within the inflammasome
complex that is assembled when pathogen-associated molecular
patterns (PAMPs) are sensed in the cytosol by special host receptors.
These cytosolic receptors belong to the nucleotide binding
oligomerization domain-leucine rich repeat proteins (NOD-like-
receptors or CATERPILLAR family of proteins) [7–12]. A variety
of pathogens such as Shigella, Francisella, Salmonella, Listeria,
Pseudomonas, Escherichia coli and Legionella activate caspase-1,engaging
different NOD-like-receptors [13–18].
L. pneumophila is an intracellular bacterium and the causative
agent of Legionnaires’ pneumonia [19]. The ability of L.
pneumophila to cause pneumonia is dependent on its tendency to
invade and multiply within human macrophages [20–23]. Once
phagocytized, the bacteria reside in specialized vacuoles [20–26].
The L. pneumophila-containing phagosome does not fuse with the
lysosome and instead acquires vesicles from the endoplasmic
reticulum (ER) [20–26]. Within this vacuole, L. pneumophila
multiply exponentially [27]. In contrast, macrophages from most
mouse strains are restrictive to L. pneumophila infection. Within
mice cells, L. pneumophila flagellin is sensed by Nlrc4 leading to the
activation of caspase-1 [7,28–30], whereas in human macropha-
ges, caspase-1 is not activated in response to L. pneumophila.
Caspase-1 activation in mouse macrophages is accompanied with
L. pneumophila restriction due to the delivery of organisms to the
lysosome for degradation and early macrophage death [28,31].
Furthermore, pharmacological inhibition of caspase-1 in wild-type
macrophages allows more L. pneumophila replication [28,31,32].
Accordingly, mouse macrophages that do not activate caspase-1 in
response to L. pneumophila such as Nlrc4
2/2 and caspase-1
2/2 cells
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macrophages are also permissive to L. pneumophila intracellular
replication despite caspase-1 activation [28,29,33–36]. The
downstream mechanism responsible for the permissiveness of
macrophages lacking Nlrc4, caspase-1 or functional Naip5 is still
unclear.
In vitro experiments revealed that caspase-1 directly processed
procaspase-3 and -7 [37,38]. Nevertheless, the biological role of
this activation is unknown. Furthermore, whether this reaction is
pertinent to the apoptosis or to the inflammation pathway or
whether it mediates a yet unidentified effect is not clear.
Here we demonstrate that caspase-7, but not caspase-3, was
activated in restrictive wild-type mouse macrophages by L.
pneumophila. Caspase-7 activation by low multiplicity of L.
pneumophila infection was dependent on Nlrc4, caspase-1 and
functional Naip5. Such activation was accompanied by enhanced
fusion of the L. pneumophila-containing phagosome with the
lysosome and early death of infected cells resulting in restriction
of infection in wild-type macrophages. The activation of caspases-
8 and -9 which are involved in caspase-7 activation in response to
apoptotic signals was not necessary for L. pneumophila-mediated
caspase-7 activation. In contrast to caspase-7, caspase-3 was not
activated by L. pneumophila in wild-type macrophages and its
absence did not affect the activation of caspase-7 or the
intracellular fate of the organism. The effect of caspase-7
activation on L. pneumophila growth was independently of IL-1b
and IL-18. Remarkably, caspase-7 activation also controlled the
growth of the pathogen within the murine lungs in vivo.
Therefore, our data identify a previously uncharacterized
signaling pathway for caspase-7 activation through Nlrc4,
caspase-1 and Naip5. We also demonstrate a new role for
caspase-7 in host defense against an intracellular bacterium. These
findings may be valuable in the design of compounds that could
restrict the growth of not only L. pneumophila but also other
organisms that tend to avoid lysosomal fusion.
Results
Caspase-7 is activated by wild-type L. pneumophila
L. pneumophila infection leads to caspase-1 activation in
macrophages. The activation of caspase-1 is accompanied by
restriction of L. pneumophila growth in macrophages and in mice
[28,31]. However, the downstream signaling pathway involved in
the control of L. pneumophila growth is not known. In vitro studies
suggested that caspase-1 can cleave caspase-7 and caspase-3
[37,38]. However, it is not known if this reaction takes place in vivo
during L. pneumophila infection. Therefore, we investigated whether
caspase-7 and caspase-3 are cleaved within wild-type C57BL/6
macrophages upon L. pneumophila infection. Assessment of different
multiplicity if infection (MOI) revealed that caspase-7 was
activated at MOI ranging from 0.5 to 20 within 2 hours of
infection. Caspase-1 activation was determined by the detection of
the corresponding mature subunits in cell extracts in western blots
using specific anti-caspase-1 antibodies (Figure 1A and 1B and
Figure S1A). Infection of wild-type murine macrophages was
accompanied by caspase-7 activation only in the presence of a
functional Dot/Icm type IV secretion system, a bacterial
apparatus that injects bacterial products into the host cytosol
(Figure 1A and 1C). The bacteria induced proteolytic cleavage of
pro-caspase-7 within 30 minutes even at low MOI (Figure 1B).
Therefore, L. pneumophila activates caspase-7 in macrophages in a
Dot/Icm-dependent manner.
Bacterial flagellin mediates caspase-7 activation via the
host protein Nlrc4
Since L. pneumophila flagellin triggers caspase-1 activation via the
NOD-like receptor Nlrc4 [7,28], we tested whether a L.
pneumophila mutant lacking flagellin (Fla) induced caspase-7
activation. We infected wild-type macrophages with L. pneumophila
or with the Fla mutant lacking flagellin and examined the
activation of caspase-7 (Figure 1C). To ensure equal internaliza-
tion of wild-type and flagellin-deficient L. pneumophila, infections
were followed by mild centrifugation to enhance contact between
macrophages and mutant bacteria. Under these conditions, we
recovered equal numbers of bacteria at 1 hour post-infection (data
not shown). Unlike wild-type bacteria, the L. pneumophila Fla
mutant failed to induce caspase-7 activation even at high MOI
(Figure 1C, Figure S1B, and Figure S1C). Since flagellin is sensed
by the host receptor Nlrc4, we tested if caspase-7 activation by L.
pneumophila requires Nlrc4. Caspase-7 activation by wild-type L.
pneumophila was abrogated in macrophages lacking Nlrc4
(Figure 1C). To verify the role of flagellin in caspase-7 activation,
purified bacterial molecules were delivered intracellularly using
streptolysin O (SLO), a protein that allows delivery of exogenous
molecules into the cytosol of living cells [28,39]. Bacterial flagellin,
bacterial lipoproteins (LP), RNA, DNA, or lipopolysaccharide
(LPS) activated caspase-7 when delivered to the cytosol using SLO
(Figure 1C and 1D). However, flagellin required Nlrc4 for caspase-
7 activation (Figure 1C and 1D). The low concentration and short
time of SLO treatment used to deliver flagellin to the cytosol did
not activate caspase-7 in the absence of bacterial ligands
(Figure 1C). Therefore, caspase-7 activation by L. pneumophila is
mediated by the bacterial flagellin through the host sensor Nlrc4.
To rule out the contribution of Toll-Like Receptor (TLR)
signaling in caspase-7 activation by L. pneumophila, macrophages
lacking the TLR adaptor molecules MyD88 or TRIF were
infected and examined for activation of caspase-7. The lack of
MyD88 or TRIF did not prevent caspase-7 activation by L.
pneumophila (Figure S2A and Figure S2B). These results indicate
Author Summary
Legionella pneumophila causes a severe form of pneumo-
nia called Legionnaires’ disease. In human macrophages, L.
pneumophila establishes special vacuoles that do not fuse
with the lysosome and grows intracellularly. However, in
mouse macrophages, the bacteria are efficiently delivered
to the lysosome for degradation. Importantly, caspase-1 is
activated when L. pneumophila infects mouse macrophag-
es, but not when it infects human cells. Caspase-1
activation promotes the fusion of the L. pneumophila
vacuole with the lysosome and macrophage death.
However, the caspase-1 substrate mediating such effects
is unknown. Experiments performed in vitro demonstrate
that caspase-7 is a substrate of caspase-1. Yet, it is not
known if the reaction takes place within the macrophage,
and it is unclear if it has any biological effect. In this study
we show that, in mouse macrophages, caspase-7 is
activated by L. pneumophila downstream of caspase-1
and requires the host receptors Nlrc4 and Naip5.
Remarkably, caspase-7 activation during L. pneumophila
infection restricts growth by promoting early macrophage
death and efficient delivery of the organism to the
lysosome. Consequently, L. pneumophila grows in the
macrophages and the lungs of caspase-7
2/2 mice.
Therefore, we demonstrate a novel caspase-7 activation
pathway that contributes to the restriction of L. pneumo-
phila infection.
Caspase-7 Activation Restricts Legionella
PLoS Pathogens | www.plospathogens.org 2 April 2009 | Volume 5 | Issue 4 | e1000361that the sensing of flagellin through Nlrc4 mediates caspase-7
activation by L. pneumophila independently of TLRs.
Caspase-7 activation by L. pneumophila infection is
dependent on caspase-1, but not caspase-3
Nlrc4 is indispensable for caspase-1 and caspase-7 activation by L.
pneumophila.However, it is not clear if caspase-1 activation is upstream
of caspase-7 as suggested by the invitroexperiments [38]. To assess the
role of caspase-1 in caspase-7 activation during early stages of
infection, caspase-1
2/2 macrophages were infected with low MOI of
L. pneumophila. Particularly, caspase-7 activation by L. pneumophila was
abolished in the absence of caspase-1 (Figure 2A), whereas caspase-1
activationby L.pneumophiladid not require caspase-7 (Figure 2B). This
result suggests that caspase-7 is downstream of the caspase-1
activation pathway. However, at high MOI caspase-7 was activated
independently of caspase-1 (Figure S1B).
To verify if the enzymatic activity of caspase-1 contributes to the
induction of caspase-7 activation by low MOI of L. pneumophila,w e
inhibited caspase-1 activity with the caspase-1 inhibitor Z-YVAD-
FMK and examined caspase-7 activation upon L. pneumophila
infection. Pharmacological inhibition of caspase-1 abolished
caspase-7 activation by L. pneumophila (Figure S3A). Taken together,
our data show that caspase-1 enzymatic activity is necessary for
caspase-7 activation by L. pneumophila in macrophages.
Caspase-7 and caspase-3 are activated during apoptosis via the
intrinsic and extrinsic pathways through caspase-8 and -9 [3].
Figure 1. The host protein Nlrc4 and bacterial flagellin are required for the induction of caspase-7 activation by L. pneumophila. (A)
Wild-type C57BL/6 (B6) derived macrophages were not treated (No treat) or infected with wild-type L. pneumophila (Leg) at different multiplicities of
infection (MOI) (3-0.5) or with L. pneumophila type IV secretion mutant (Dot) at an MOI of 1 for 2 hrs. (B) B6 derived macrophages were infected with
Leg at an MOI of 0.5 for different durations. (C,D) B6 and Nlrc4
2/2 macrophages were infected with Leg, the Dot mutant, the mutant lacking flagellin
(Fla) (MOI of 0.5) or treated with streptolysin O (SLO) alone, flagelin alone (flagel), or SLO and purified flagel (C), or treated with SLO and bacterial
lipoprotein (LP), bacterial RNA, bacterial DNA, or bacterial lipopolysaccharide (LPS) (D). (A–D) Immunoblots were developed with anti-caspase-7
antibody and are representative of more than three independent experiments.
doi:10.1371/journal.ppat.1000361.g001
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mediated caspase-7 activation, caspase-3
2/2 macrophages were
infected with L. pneumophila and examined for the cleavage of
caspase-1 and caspase-7. Our data demonstrate that the absence
of caspase-3 had no effect on pathogen-mediated activation of
caspase-1 (Figure 2B) or of caspase-7 (Figure 2C). These data
support the fact that caspase-3 was not activated by L. pneumophila
in wild-type C57BL/6 macrophages although activated in A/J-
derived macrophages (Figure 2D). Second, to test the role of the
initiator caspase-8 and -9 in caspase-7 activation by L. pneumophila
infection, the pathogen was added to macrophages pretreated with
the caspase-8 inhibitor (Z-IETD-FMK), or caspase-9 inhibitor (Z-
LEHD-FMK), then cell lysates were examined for caspase-7
activation. In contrast to caspase-1 inhibition, the pharmacological
inhibition of caspase-8 or -9 did not compromise caspase-7
activation by L. pneumophila (Figure 3A). However, inhibition of
caspase-8 and -9 activities compromised caspase-7 activation
induced by the apoptosis inducer doxorubicin (Figure S3B). These
results indicate that caspase-7 activation by L. pneumophila is
independent of caspase-8 or -9.
Naip5 is essential for caspase-1–mediated activation of
caspase-7 by L. pneumophila
With the exception of the A/J mouse, most mouse strains are
resistant to L. pneumophila [20,36,40]. The permissiveness of the A/
J mouse is attributed to a polymorphism in the gene encoding the
neuronal apoptosis inhibitory protein (Naip5) [34,35,41]. The
susceptibility of A/J-derived macrophages to L. pneumophila is
independent of caspase-1 activation since the levels of activation in
the presence of wild-type and A/J-derived Naip5 are comparable
[28,29,33]. Given that caspase-7 activation is mediated down-
stream of caspase-1 in wild-type macrophages, we tested if Naip5
plays a role in caspase-7 activation by L. pneumophila. Caspase-7
activation by L. pneumophila was compromised in macrophages
derived from A/J-derived macrophages (Naip5
AJ) (Figure 2E).
Similar results were obtained using transgenic C57BL/6 mice
harboring the mutant A/J-derived Naip5 (data not shown) [42].
These findings suggest that L. pneumophila–mediated caspase-7
activation downstream of the caspase-1 inflammasome requires
Naip5.
Caspase-7 activation restricts L. pneumophila replication
in macrophages and in mice
Caspase-1 activation restricts L. pneumophila intracellular survival
and replication [28,31]. However, the downstream effectors
responsible for the control of L. pneumophila growth are still
unknown. Given that caspase-7 activation by L. pneumophila is
dependent on caspase-1 activation, we investigated if caspase-7
controls L. pneumophila replication. Wild-type, caspase-3
2/2,
caspase-7
2/2 and caspase-1
2/2 macrophages were infected with
L. pneumophila and intracellular bacterial replication was evaluated
by quantifying the colony forming units (CFUs) throughout
72 hours of infection and by microscopy after 24 hours.
Remarkably, macrophages lacking caspase-7 allowed substantial
L. pneumophila replication when compared to wild-type cells
(Figure 3A and 3B). The number of CFUs recovered from
caspase-7
2/2 macrophages were comparable to the number
recovered from their caspase-1
2/2 counterparts (Figure 3A and
3B). Peritoneal macrophages from caspase-7
2/2 mice were also
highly permissive for L. pneumophila replication (data not shown).
To confirm the role of caspase-7 in L. pneumophila restriction,
caspase-7
2/2 macrophages were complemented with caspase-7
plasmid and examined for the correlation between caspase-7
expression and bacterial replication. The delivery of a caspase-7
plasmid to primary caspase-7
2/2 macrophages was performed
using transfection (Superfect) or nucleofection (Amaxa). Although
caspase-7 was expressed using both techniques, nucleofection was
detrimental to the cells (Figure S4A and data not shown).
Expression of caspase-7 using Superfect was sufficient to restore
the ability of murine macrophages to restrict L. pneumophila growth
Figure 2. Caspase-1 and Naip5 are required for caspase-7 activation by L. pneumophila. (A) Wild-type C57BL/6 (B6) and caspase-1
2/2
(casp-1
2/2) derived macrophages were not treated (No treat) or infected with L. pneumophila (Leg), or the mutant lacking flagellin (Fla) for 2 hr. Cell
lysates were analyzed by western blot with anti–caspase-7 antibodies. (B) B6, caspase-7
2/2 (casp-7
2/2), and caspase-3
2/2 (casp-3
2/2) macrophages
were treated with wild-type Leg or with Fla mutant, then cell lysates were analyzed by western blot with anti–caspase-1 antibodies. (C) B6 and casp-
3
2/2 were infected with Leg, then cell lysates were examined by western blots with anti–caspase-7 antibodies. (D,E) B6– and A/J–derived
macrophages (Naip5
AJ) were infected or not with Leg for times indicated, then cell lysates were examined by western blot with anti–caspase-3 (D) or
–caspase-7 (E) antibodies.
doi:10.1371/journal.ppat.1000361.g002
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plasmid carrying the red fluorescent protein (RFP) or green
florescent protein (GFP) by the same techniques did not alter the
permissiveness of the caspase-7
2/2 macrophages to L. pneumophila
(Figure S4B and data not shown).
Since caspase-1 activity was necessary for L. pneumophila-
mediated caspase-7 activation (Figure S3A), we tested if inhibition
of caspase-1 activity permitted more bacterial replication.
Distinctly, the inhibition of caspase-1 activity by Z-YVAD-FMK
allowed more bacterial growth in wild-type B6 macrophages
(Figure 3C). Unlike caspase-1 inhibition, the inhibition of caspase-
8, -9 or -3 did not allow L. pneumophila replication in B6
macrophages (Figure 3C). Therefore, caspase-1 enzymatic activity
is required for L. pneumophila growth restriction in macrophages.
Unlike caspase-7, and despite the suggested similarity in small
substrate specificity, the absence of caspase-3 had no effect on L.
pneumophila growth in macrophages (Figure 3A).
Since Legionnaires’ disease is caused by the replication of
L. pneumophila in alveolar macrophages, we investigated if caspase-
7 regulates bacterial growth within the lungs of mice in vivo.
Wild-type and caspase-7
2/2 mice were infected intratracheally
with 1610
6 CFU of L. pneumophila and the number of bacteria in
the lungs was determined at 96 hours post-infection (Figure 3D).
The lungs of caspase-7
2/2 mice supported substantially more L.
pneumophila CFUs than their wild-type counterparts (Figure 3D),
although initial bacterial counts in the lungs were identical
(Figure 3E). Therefore, these results indicate that caspase-7
restricts L. pneumophila replication both in vitro and in vivo.
Caspase-1–dependent caspase-7 activation contributes
to L. pneumophila phagosome maturation in
macrophages
In wild-type macrophages, a fraction of phagocytized L.
pneumophila are contained inside phagosomes that rapidly fuse
with lysosomes [22,43,44]. To determine the mechanism by which
caspase-7 controls L. pneumophila growth in macrophages, we
observed the trafficking of the organism intracellularly. First, we
examined the rate of acquisition of the lysosomal-associated
membrane protein-1 (LAMP-1) by phagosomes harboring L.
Figure 3. Caspase-7 restricts L. pneumophila replication in macrophages and in mice. (A) Wild-type C57BL/6 (B6), caspase-3
2/2 (casp-3
2/2),
caspase-7
2/2 (casp-7
2/2), or caspase-1
2/2 (casp-1
2/2) macrophages were infected with wild-type L. pneumophila, then colony forming units (CFU)
were scored at indicated time points. The results represent the mean of four independent experiments 6SD. (B) B6, casp-1
2/2, or casp-7
2/2
macrophages were infected with GFP–expressing L. pneumophila for 24 hrs and examined by fluorescence microscopy. (C) B6 macrophages were
treated or not with 50 mM caspase-1 inhibitor (YVAD), caspase-8 inhibitor (IETD), caspase-9 inhibitor (LEHD), or caspase-3 inhibitor or
dimethylsulfoxide alone (DMSO) 45 min before infection with L. pneumophila. Cells were lysed and the number of colony forming units (CFU) was
quantified at 1, 24, and 48 hrs post infection. The results represent the mean of three independent experiments 6SD. (D) B6 and caspase-7
2/2 mice
received 10
6 wild-type L. pneumophila intra-tracheally. Lungs were homogenized and plated for CFUs at 96 hrs post-infection. Data were analyzed by
Student’s t-test. *, P value#0.05. (E) B6 and caspase-7
2/2 mice were infected with L. pneumophila for 6 hrs and lungs were examined for bacterial
load as described in D.
doi:10.1371/journal.ppat.1000361.g003
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of the phagosomes containing the pathogen co-localized with
LAMP-1 within 30 min post-infection, less than 30% of the L.
pneumophila containing vacuoles in caspase-7
2/2, caspase-1
2/2
and A/J-derived macrophages acquired LAMP-1 (Figure 4A and
4B).
Next, to test if caspase-7
2/2 macrophages contained a general
defective phagosome-lysosome fusion function, we examined the
ability of the non-pathogenic type IV secretion mutant (Dot) to
traffic to the lysosome. In contrast to pathogenic wild-type L.
pneumophila, caspase-7
2/2 macrophages efficiently delivered the
Dot mutants to LAMP-1 labelled compartments within 2 hours of
internalization (Figure S5A). Then, in order to assess the role of
caspase-7 in mediating L. pneumophila degradation [28,45],
macrophages were infected with L. pneumophila, and the intact
rod-shaped and degraded distorted-shaped bacteria were differ-
entiated by labelling with anti-L. pneumophila antibody as previously
described (Figure S5B). In wild-type macrophages, by 2 hours
post-infection, about 40% of internalized bacteria lost their rod-
shaped contour and were degraded into multiple small rounded
particles compared to only 10 % in caspase-7
2/2 macrophages
(Figure S5B).
Given that the L. pneumophila-containing phagosome in permis-
sive cells acquires ER-derived vesicles [20,22,26], we examined the
recruitment of calreticulin, an ER protein, to phagosomes
harboring L. pneumophila. By 4 hours post-infection, around 35%
of the bacteria co-localized with calreticulin in caspase-7
2/2
macrophages, whereas less than 5% bacteria associated with the
ER marker in B6 macrophages (Figure 4C and 4D). The
trafficking of L. pneumophila in caspase-7
2/2 macrophages was
comparable to that in the caspase-1
2/2 and A/J-derived
counterparts (Figure 4A and 4C). Therefore, caspase-7 activation
promotes the fusion of the L. pneumophila-containing phagosome
with the lysosome mediating the degradation of the pathogen.
Caspase-7 activation and restriction of L. pneumophila
growth is independent of IL-1b and IL-18
Caspase-7 activation by L. pneumophila is regulated by caspase-1
which also regulates the maturation of the pro-inflammatory
cytokines IL-1b and IL-18 [2,5]. Our data show that caspase-7
activation is mediated by Nlrc4 and caspase-1 (Figure 1C and
Figure 2A and 2E). To examine the possibility that caspase-7 is
downstream of IL-1b and IL-18, we infected wild-type and IL-1b/
IL-18 double knockout-derived macrophages with L. pneumophila
and examined the activation of caspase-7. The absence of IL-1b
and IL-18 did not prevent caspase-7 activation by L. pneumophila
infection (Figure S6A). Next, to test if IL-1b and IL-18 control L.
Figure 4. L. pneumophila–containing phagosomes avoid the fusion with the lysosome in caspase-7
2/2, caspase-1
2/2, and A/J–
derived macrophages but not in wild-type macrophages. Macrophages from wild-type C57BL/6 (B6), caspase-7
2/2 (casp-7
2/2), caspase-1
2/2
(casp-1
2/2), or A/J mice were seeded on cover slips and infected with L. pneumophilla. The internalized bacteria were quantified for co-localization
with the late endosomal marker LAMP-1 (A and B), or for the localization with the endoplasmic reticulum marker calreticulin at times indicated (C and
D). Data represent the mean of three independent experiments 6SD.
doi:10.1371/journal.ppat.1000361.g004
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infected and bacterial growth was quantified throughout 72 hours.
Cells lacking IL-1b and IL-18 did not allow L. pneumophila
replication intracellularly when compared with their caspase-7
2/2
and A/J-derived counterparts (Figure S6B). To further understand
the role of IL-1b and IL-18 in infection, recombinant mouse IL-1b
(rIL-1b) or IL-18 (rIL-18) was added to B6 and caspase-7
2/2
macrophages upon L. pneumophila infection. Exogenous cytokines
had no effect on the growth of the pathogen whether caspase-7
was present or not (Figure S6C). Next, to examine the role of IL-
1b and IL-18 receptors during L. pneumophila infection, corre-
sponding antibodies to IL-1 receptor and IL-18 receptor were
added during infection. The intracellular growth of L. pneumophila
in macrophages in the presence of the antibodies was identical to
that of untreated cells (Figure S6C). Our data demonstrate that
despite being downstream of caspase-1, IL-1b and IL-18 do not
play a role in caspase-7 activation by L. pneumophila or restriction of
macrophage infection.
To determine if caspase-7 is upstream of IL-1b and IL-18 and
hence controls their activation, we examined IL-1b and IL-18
release in culture supernatants of wild-type and caspase-7
2/2
macrophages in response to different organisms. IL-1b was
released by L. pneumophila in the presence or absence of caspase-
7 after 24 hours of infection. However, IL-18 was barely detected
in both macrophage cell types in response to L. pneumophila (data
not shown). Similarly, within 24 hrs of infection, IL-1b was
released by wild-type and caspase-7
2/2 macrophages in response
to Salmonella typhimurium (Salmonella) (Figure S7A and Figure S7B).
These results demonstrate that caspase-7 does not regulate the
caspase-1–dependent inflammatory substrates IL-1b or IL-18.
Caspase-7
2/2 macrophages delay apoptosis during early
stages of infection by L. pneumophila
Our data show that at physiological stages of infection, L.
pneumophila leads to caspase-7 activation in a caspase-1–dependent
manner (Figure S1). Nevertheless, when high numbers of
organisms invade the macrophage, caspase-7 is induced indepen-
dent of caspase-1.
It has been shown that macrophage cell death contributes to the
restriction of L. pneumophila infection [44,46]. Therefore, we
examined the role of caspase-7 in induction of cell death during
L. pneumophila infection at different MOIs and durations of
infection. First we measured LDH release in the overall population
of macrophages infected with low MOI for 24 hrs. Minimal cell
death was detected in response to wild-type organism in infected
macrophages whether they expressed caspase-7 or not (Figure 5A).
To better understand the role of caspase-7 in L. pneumophila-
mediated cell death, we measured macrophage apoptosis and
necrosis in the overall population of macrophages by determining
the cytoplasmic (apoptosis) and extracellular (necrosis) histone-
associated-DNA-fragments during low and high MOI. Low MOI
of L. pneumophila infection lead to minimal apoptosis after 24 hrs of
infection in WT macrophages and in those lacking caspase-7, -1, -
3, or functional Naip5 (Figure 5B). However, at high MOI, L.
pneumophila induced significant apoptosis within 2 hrs of infection
in all macrophages except those lacking caspase-1 (Figure 5C).
Indeed, after 24 hrs of high MOI, all macrophages were apoptotic
irrespective of their type (data not shown).
At low MOI, around 20% of macrophages were necrotic after
24 hrs of infection (Figure 5D). The high bacterial MOI did not
dramatically increase the number of necrotic cells within 2 hrs of
infection (Figure 5E).
To follow the role of apoptosis in L. pneumophila infection,
apoptosis of individual cells after labeling of DNA strand breaks
(TUNEL) was quantified by fluorescence microscopy. We scored
100 infected cells and quantified how many of those were TUNEL
positive. Within 2 hrs of infection at low MOI, no more than 2%
of infected macrophages lacking caspase-1, -7 or functional Naip5
were TUNEL positive whereas 20% infected wild-type macro-
phages were apoptotic (Figure 5F). After 24 hrs of infection, the
majority of infected wild-type, caspase-7
2/2 and A/J-derived
macrophages were apoptotic while infected caspase-1
2/2 macro-
phages did not show signs of apoptosis even when harboring
several bacteria (Figure 5F). Remarkably, after the 24 hrs
infection, many wild-type B6 macrophages that did not seem to
harbor bacteria also underwent apoptosis (data not shown).
Therefore, infected wild-type macrophages respond to L. pneumo-
phila infection by early apoptosis which render them unsuitable for
optimal bacterial replication.
Then, to investigate the role of apoptosis in vivo, we infected
wild-type, caspase-1
2/2, caspase-7
2/2 and A/J-derived macro-
phages intratracheally for three days. Then, harvested infected
lung sections were stained with TUNEL to detect apoptotic cells.
The degree of apoptosis observed in lung tissues was comparable
among different infected lungs (Figure S8). These results suggest
that apoptosis may not play a major role in L. pneumophila infection
in vivo especially at latter stages of infection.
Caspase-1 and caspase-7 activation are not detected in
human monocytes in response to L. pneumophila
infection
Human monocytes are permissive to L. pneumophila [20,47]. The
failure of human cells to restrict L. pneumophila infection is still
under extensive studies. Remarkably, Caspase-1 activation is not
detected during L. pneumophila infection of human cells [48]. To
investigate the role of caspase-7 in human cells, we examined
caspase-1 and capsase-7 activation in fresh human monocytes
infected with L. pneumophila or with Salmonella. Caspase-1 was
strongly activated in response to Salmonella but not in response to L.
pneumophila. Similarly, caspase-7 was activated during Salmonella
infection but not during L. pneumophila infection (Figure S9A and
Figure S9B). Therefore, caspase-1 and caspase-7 are not activated
in human monocytes upon L. pneumophila infection.
Taken together, our data show that the lack of caspase-7
activation is associated with permissiveness to L. pneumophila
infection in mice and in humans.
Discussion
The ability of L. pneumophila to survive in human cells presents a
challenge to host defense. One common strategy for the host to
deal with intracellular infection is to eliminate infected cells by
caspase-mediated apoptosis. However, emerging reports demon-
strate new functionally distinct roles for executioner caspases
independent of cell death [1,49]. Another strategy for eliminating
intracellular bacteria is to deliver them to the lysosome for
degradation. However, several pathogens have developed ways to
deter such fate [43,50–52].
Here we reveal a novel role for caspase-7 in host defense against
L. pneumophila. We have identified a new activation pathway for
caspase-7 that requires Nlrc4 and caspase-1, independent of the
classical apoptosis pathway employing caspase-8 and -9. We also
show that Naip5 contributes to caspase-7 activation downstream
of caspase-1 during physiological levels of infection.
Caspase-7 activation restricts L. pneumophila infection in vitro and
in vivo. This restriction is lost in caspase-7
2/2 macrophages, but
restored after expression of caspase-7 via transfection (Figure S4).
Taken together, the role of caspase-7 in restriction of L. pneumophila
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may cause permissiveness to L. pneumophila such as Nramp-1 or
Naip5 are responsible is ruled out [34,40].
To recognize the role of caspase-7 during different stages of
infection and different MOI, we pursued macrophage infections
with low MOI (0.5) or high MOI (20). Under low MOI, caspase-7
activation by L. pneumophila required Nlrc4 and caspase-1 (Figures 1
and 2). It is possible that caspase-1 is required for the proper
assembly of the Nlrc4-inflammasome while the cleavage of
caspase-7 is mediated by another unidentified molecule. This
possibility was deemed unlikely since the pharmacological
inhibition of caspase-1 activity abolished caspase-7 activation in
response to L. pneumophila (Figure S3) and because caspase-1
directly cleaves pro-caspase-7 in vitro [38].
In addition to flagellin, bacterial ligands not sensed by Nlrc4 but
known to activate caspase-1 through other NOD-like receptors
also led to caspase-7 activation, suggesting that this may apply to
other inflammasome complexes (Figure 1D). The role of caspase-7
activation in response to organisms that engage different
inflammasomes remains to be elucidated.
L. pneumophila-triggered caspase-7 activation is distinct from the
activation seen during apoptosis, as inhibition of caspases-8 or -9
did not prevent activation following L. pneumophila infection (Figure
S3), nor did it permit additional bacterial growth (Figure 3C). Our
results show that, along with taking part in apoptosis, caspase-7
activation performs an additional unrecognized role.
The route of intracellular trafficking of L. pneumophila affects at
least in part, the outcome of infection [20,23,25,26,47,53,54], but
the factors that dictate this route are not very well understood.
Here we show that in caspase-7
2/2 macrophages, only 20% of the
internalized L. pneumophila were delivered to the lysosome as early
as 30 min after infection. Within 4 hrs, less than 10% of the
bacteria were still in the lysosome while 40% resided in
endoplasmic reticulum-labelled vacuoles (Figure 4). Further, there
were more rod-shaped (undegraded) organisms in the absence of
caspase-7 (Figure S5). Therefore, the restriction of infection in
macrophages is achieved at least in part, by the delivery of more
organisms to the lysosome when caspase-7 is activated.
The presumptive role of caspase-7 as an executioner caspase,
involved in the cleavage of apoptotic substrates, is based primarily
on its close relationship with caspase-3. However, recent reports
demonstrate that caspase-7 and caspase-3 are functionally distinct
[46,55]. As reported by others, we found that unlike caspase7,
caspase-3 was activated by L. pneumophila in A/J-derived
macrophages and not in wild-type macrophages (Figure 2D).
Therefore, our data demonstrate that caspase-3 and caspase-7 are
not simultaneously activated during L. pneumophila infection as they
are during apoptosis.
Furthermore, the absence of caspase-7 but not caspase-3 was
accompanied with permissiveness to L. pneumophila infection in vitro
and in vivo (Figure 3). Caspase-3 is also activated independently of
the classical apoptosis pathways [55,56], and reports have
suggested that caspase-3 activation promotes cell survival [57].
Several studies suggest that caspase-3 activation is essential for
establishment of L. pneumophila infection by mediating the cleavage
of Rabaptin5 [55,56]. These data strongly suggest different roles of
caspase-7 versus caspase-3, as they restrict and permit L.
pneumophila infection, respectively (Table S1).
Interestingly, TUNEL analysis of infected macrophage popu-
lation revealed that during the first 2 hrs of infection, 20% of
Figure 5. The role of caspase-1 and -7 in L. pneumophila–induced apoptosis at different multiplicities of infection (MOI). (A) Wild-type
C57BL/6 (B6), casp-7
2/2, and casp-3
2/2 macrophages were not treated (striped bars), or treated with wild-type L. pneumophila (black bars), type IV
secretion mutant (white bars), or flagellin mutant (grey bars) at MOI of 0.5 for 24 hrs, then percent cell survival was measured by LDH release from
overall population of macrophages. Analysis of apoptosis (B and C) or necrosis (D and E) of macrophages not infected (white bars) or infected (grey
bars) with wild-type L. pneumophila at an MOI of 0.5 for 24 hrs (B and D) or MOI of 20 for 2 hrs (C and E) by ELISA photometric enzyme immunoassay
analysis of the cytoplasmic (apoptosis) and extracellular (necrosis) histone-associated-DNA-fragments. (F) Microscopic single cell analysis of apoptosis
by TUNEL staining after 2 hrs (white bars) and 24 hrs (black bars) of infection with wild-type L. pneumophila at MOI of 0.5. The y axis represents the
number of TUNEL positive (TUNEL
+) macrophages among 100 infected macrophages. *, P value#0.05. (A–F) The results represent the mean of three
independent experiments 6SD.
doi:10.1371/journal.ppat.1000361.g005
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the optimal replication of the organism, whereas infected
macrophages lacking caspase-7, -1 or a functional Naip5 did not
undergo early apoptosis (Figure 5F). These data agree with
previous reports that suggest that L. pneumophila delay apoptosis in
permissive macrophages to allow for the establishment of the
replicative vacuole [46,58]. Since early apoptosis is delayed in
macrophages lacking caspase-1, caspase-7, or functional Naip5,
and since these cell types are defective in caspase-7 activation in
response to L. pneumophila, we conclude that caspase-7 activation
contributes to early apoptosis observed in wild-type macrophages.
However, our conclusion does not rule out the contribution of
other mechanisms [55,59,60].
High MOI led to significant apoptosis in wild-type, caspase-7
2/2
and A/J-derived macrophages but not in caspase-1
2/2 cells
(Figure 5C). Hence, caspase-1 appears as a more general regulator
of L. pneumophila-triggered apoptosis. Caspase-7, however, regulated
apoptosis only in the early stage of infection at low MOI. Similarly,
Korfali et al showed that caspase-7 is involved earlier than other
effector caspases in the apoptotic execution process in DT40 B
lymphocytes [61]. Despite this, L. pneumophila replicated to a similar
extent in macrophages lacking caspase-1 or caspase-7 (Figure 3),
suggesting that for L. pneumophila to establish infection, it is
particularly important to delay apoptosis during the early stages of
infection.
Lungs from infected mice did not show significant differences in
apoptosis after 3 days whether they lacked caspase-1, caspase-7, or
a functional Naip5 (Figure S8). This does not exclude the role of
cell death in vivo but strongly suggests that there must be at least
one other complementary mechanism employed through caspase-
7 to restrict infection.
Macrophages harbouring A/J Naip5 allele are capable of
caspase-1 activation in response to L. pneumophila as reported by
our group and by Lightfield et al [28,29,33], nevertheless, they are
defective in caspase-7 activation (Figure 2E). Therefore, it is
possible that the lack of caspase-7 activation is responsible at least
in part, for the permissiveness of the A/J cells to L. pneumophila
infection. Increasing evidence suggest that the Naip family of
proteins may have yet uncharacterized functions [33,62–64]. We
propose that wild-type Naip5 mediates the activation of caspase-7
by caspase-1 during infections at low MOI. Our suggestion is
supported by the fact that Naip5 interacts with Nlrc4 (which binds
caspase-1) and with caspase-7 [31,48,65].
However, recent reports showed that the complete absence of
Naip5 prevents caspase-1 activation [33]. The authors suggested
that Naip5 is upstream of caspase-1, but it is possible that that
Naip5 is required for proper assembly of the Nlrc4 inflammasome
and hence caspase-1 activation but that A/J-derived Naip5 is
partially functional as suggested by the authors [33]. This partial
functionality may permit inflammasome assembly and caspase-1
activation but fail to mediate downstream caspase-7 activation, as
suggested by our results. The isolation of the Nlrc4 inflammasome
and identification of its components could clarify these possibilities.
Since IL-1b and IL-18 are downstream of caspase-1 and IL-1b
has been implicated in controlling the maturation of the
phagosome containing the Mycobacteria zmp-1 mutant, we
examined the role of IL-1b and IL-18 in L. pneumophila infection
and in caspase-7 activation [66,67]. IL-1b/IL-18 double knockout
macrophages restricted L. pneumophila infection as efficiently as
wild-type macrophages (Figure S6B). In addition, caspase-7
activity in the double-knockout cells was equal to that in wild-
type cells (Figure S6A). Finally, exogenously-added IL-1b or
antibodies against the corresponding receptors did not alter the
number of L. pneumophila as measured by colony-forming-unit
assays (Figure S6C). Therefore, our model suggests that caspase-7
activation and L. pneumophila restriction are mediated downstream
of caspase-1 but independently of IL-1b and IL-18 (Table S1).
In summary, caspase-7 activation restricts L. pneumophila
infection by mediating macrophage apoptosis during early stages
of infection and by affecting the trafficking of the organism within
the cell. How caspase-7 mediates these distinct functions remains
unclear. It is possible that caspase-7 modulates host or bacterial
factors involved in controlling apoptosis and vesicular trafficking in
the cell. The identification of caspase-7 substrates during L.
pneumophila infection is the focus of ongoing work.
Therefore, our findings establish a previously uncharacterized
caspase-7 activation pathway downstream of the Nlrc4 inflamma-
some during L. pneumophila infection. Moreover, these results
demonstrate a novel biological role for caspase-7 in the control of
L. pneumophila intracellular infection in macrophages and in mice.
This new pathway can be a target for compounds that could have
therapeutic application in the context of intracellular infection.
Materials and Methods
Bacterial strains
Legionella pneumophila (L. pneumophila) strain Lp02, is a thymine
auxotrophic derivative of Philadelphia-1 [19]. The dotA mutant
strain Lp03 is defective in the Dot/Icm Type IV secretion system
[68]. The flaA mutant L. pneumophila was previously described [69].
Bacterial strains were supplemented with a plasmid that
complements thymine auxotrophy and expresses green fluorescent
protein (GFP) at the post-exponential phase (PE) [22,45]. L.
pneumophila was cultured as described previously [22,45] in ACES-
yeast extract broth supplemented with ferric nitrate and L-
cysteine. All experiments were performed in the absence of ferric
nitrate and L-cysteine from the macrophage culture medium, to
allow L. pneumophila multiplication only intracellularly. All in vitro
infections were performed at an MOI of 0.5 for 30 minutes
followed by rinsing of the infected macrophages which allowed the
infection of 20–25% of macrophages with usually 1 organism,
unless stated otherwise [28]. The quantification of the colony-
forming units (CFU) in vitro and in vivo was performed as described
[28].
Mice
Wild-type C57BL/6 (B6), caspase-7
2/2, caspase-3
2/2, and A/J
mice were previously described and purchased from the Jackson
laboratory [41,70,71]. Caspase-1
2/2 mice were from Dr. Amy
Hise at Case Western University. MyD88
2/2, TRIF
2/2, and
Nlrc4
2/2 mice were previously described [72,73]. All knockout
mice were in C57BL/6 background. Caspase-1
2/2 and caspase-
7
2/2 mice were backcrossed to C57BL/6 background for 10
generations and previously described [37,70]. IL-1b/IL-18 double
knockout mice [74] in C57BL/6 background were obtained from
Dr. A. Zynchlinsky, Max-Plank-Institute, Berlin (authorized by
Dr. S. Akira, Japan).
Macrophages
Bone marrow macrophages were prepared from femurs of five
to eight-week-old mice as previously described [28,75].
Plasmids and transfection
Mouse caspase-7 plasmid pCAGGS vector (LMBP 3818) was
obtained from Gent University in Belgium. The plasmid was
deposited by Dr. P. Vandenabeele [76]. Control plasmids used for
transfection were obtained from Amaxa (pMaxGFP) or cloned in
Dr. Wewer’s Laboratory (pLenti-dsRed). To deliver control and
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were used: transfection with SuperFect (Qiagen) and nucleofection
with Amaxa (Lonza). Briefly, in transfection, mouse macrophages
were seeded in 24-well plate at a density 0.5610
6 cells per well
24 hours prior the transfection. Next day, the media was changed
leaving 400 ml of full media per well. To make a transfection mix,
control or caspase-7 plasmids (1 mg/well) were mixed with
SuperFect reagent (2.5 ml/well) in a total volume of 100 mlo f
serum-free media for 20 minutes. Then, transfection mix was
added to the mouse macrophages bringing volume to 0.5 ml per
well. Three hours later, transfection mix was replaced with 1 ml of
full media and cells were left to recover for additional 24 hr before
adding bacteria. In nucleofection approach, 6610
6 cells were
resuspended in 100 ml of nucleofection solution (mouse macro-
phage nucleofector kit) supplemented with 10 mg plasmid.
Plasmids were delivered into macrophages with Y-01 program.
After nucleofection, macrophages were resuspended in 6 ml of full
media and 0.5610
6 cells were plated per well in 24-well plate. Cell
death was monitored throughout the assays. Bacteria were added
24 hr later.
Fluorescence microscopy
Immunofluorescence experiments were performed as previously
described [28]. L. pneumophila was detected with mouse anti-
Legionella (Abcam) and secondary Texas Red conjugated antibody.
Localization of markers on L. pneumophila phagosomes was
performed as previously described [22]. Antibodies used were
rat anti-lysosomal-associated membrane protein 1 (LAMP1;
1D4B; Developmental Hybridoma Bank) [77], rabbit anti-
calreticulin (Stressgen Bioreagents) followed by fluorescent sec-
ondary antibodies (Molecular Probes). Nuclei were stained with
nucleic acid dye 49,69-diamino-2-phenylindole (DAPI; Molecular
Probes). In each experiment one hundred bacteria were scored.
Experiments were performed at least three times. Samples were
analyzed with The Zeiss 510 META Laser Scanning Confocal
microscope and Zeiss Axioplan 2 upright microscope at The Ohio
State University Microscopy Core Facility.
L. pneumophila growth in macrophages
Macrophages were plated at 5610
5 cells per well and infected as
described above [28]. At designated time points, macrophages
were lysed and plated on AYE plates for colony forming units
(CFUs). When indicated, macrophages were treated with recom-
binant IL-1b or IL-18 (Calbiochem) or with anti-mIL-1-RI or
mIL-18 R/IL-1 R5 antibodies (R & D systems) at time of
infection. Caspase-8 inhibitor (Z-IETD-FMK), caspase-9 inhibitor
(Z-LEHD-FMK), or caspase-1 inhibitor (Z-YVAD-FMK) (Cal-
biochem) were used at 50 mM concentration when indicated.
Inhibitors were maintained during the course of infection.
Immunoblotting
Cell extracts were prepared and immunoblotted with an anti-
body that recognizes the large subunit of mouse caspase-1, -3 or -7
(Cell Signalling), followed by appropriate secondary anti-rabbit
antibody as described [28]. When indicated, macrophages were
permeabilized with 10 ng/ml streptolysin O for 5 minutes in the
absence or presence of ligands as previously described [28,39],
then rinsed and incubated for 2 hours [28]. Purified bacterial
ligands were purchased from Invivogen.
Cytokine measurements
IL-1b measurements were performed as previously described
[72,73]. Experiments were performed in triplicates.
Cytotoxicity assays
The percentage of macrophage death was determined by
measuring the release of host cell cytoplasmic LDH using the
CytoTox 96 non-radioactive cytotoxicity assay (Promega) as
previously described [28,45]. The apoptosis inducer doxorubicin
was added at 100 ng/ml, when indicated (Calbiochem). In vitro
quantification of cytoplasmic (apoptosis) and extracellular (necro-
sis) histone-associated DNA fragments was performed using The
Cell Death Detection ELISA
plus photometric enzyme immunoas-
say kit from Roche to the specifications of the manufacturer.
Apotosis of macrophages in vitro was assessed with fluorescent
TUNEL (terminal deoxynucleotidyl transferase-mediated dUTP
nick end-labelling) assay according to the manufacturer’s specifi-
cations using In Situ Cell Death Detection Kit, TMR red from
Roche. Experiments were performed in triplicates. Sections of
infected mice lungs were stained for apoptosis using Apop Tag In
Situ Apoptosis Detection Kit (Chemicon). TUNEL-positive
stained cells (brown) were evaluated by capturing digital images
using a 206objective lens and covering the entire lung (at least 32
images per lung). All samples were handled in a blinded manner.
The percent of brown pixels per high powered field (HPF) were
quantified using Adobe Photoshop CS2 software histogram
analysis.
Mouse in vivo Infection
Wild-type C57BL/6 and caspase-7
2/2 mice were infected
intra-tracheally with 1610
6 wild-type bacteria, and the number of
bacteria in the lungs was determined at 6 hours and at 96 hours
post-infection [28,75]. All animal experiments performed were
done according to animal protocols approved by the Animal Care
Use Committee of The Ohio State University College of
Medicine.
Statistical analysis
All experiments were done at least three independent times and
yielded similar results. The data points represent the average
6S.D. Data were analyzed by Student’s t-test. *, P value#0.05
and was considered significant.
Supporting Information
Figure S1 Caspase-7 activation by L. pneumophila at high
multiplicity of infection (MOI) is independent of caspase-1. (A)
Wild-type C57BL/6 (B6) and caspase-7
2/2 (casp-7
2/2) derived
macrophages were not treated (No treat) or infected with L.
pneumophila (Leg). (B) Caspase-1
2/2 (casp-1
2/2) macrophages
were not treated (No treat) or infected with Leg or the flagellin
mutant (Fla). (C) B6 and casp-7
2/2 macrophages were infected
with Fla mutant at MOI of 0.5, 5 or 20. (A–C) Infections were at
MOI of 0.5, 5, or 20 for 2 hrs, then cell lysates were analyzed by
western blots with anti-caspase-7 antibodies.
Found at: doi:10.1371/journal.ppat.1000361.s001 (0.05 MB PDF)
Figure S2 Caspase-7 activation by L. pneumophila does not
require MyD88 or TRIF. B6 and MyD88
2/2 (A), or TRIF
2/2 (B)
macrophages were infected with L. pneumophila (Leg) or with
flagellin mutant (Fla) for 2 hrs then cell lysates were analyzed by
western blot using anti-caspase-7 antibodies.
Found at: doi:10.1371/journal.ppat.1000361.s002 (0.05 MB PDF)
Figure S3 Caspase-7 activation by L. pneumophila is independent
of caspase-8 or -9. (A) Wild-type C57BL/6 (B6) macrophages were
infected with Leg in the presence or absence of 50 mM of caspase-
8 inhibitor (IETD), caspase-9 inhibitor (LEHD), or caspase-1
inhibitor (YVAD). (B) B6 macrophages were treated with the
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IETD, or LEHD or both. (A,B) Cell lysates were analyzed by
western blots with anti-caspase-7 antibody. Densitometric analysis
of the cleaved caspase-7 band is expressed relative to non-treated
samples and the values are indicated immediately below the
caspase-7 blots. The lower panels show actin blots as loading
controls.
Found at: doi:10.1371/journal.ppat.1000361.s003 (0.05 MB PDF)
Figure S4 Transfection of macrophages lacking caspase-7 with
caspase-7 plasmid restores restriction to L. pneumophila infection.
(A) Caspase-7
2/2 macrophages (Casp-7
2/2) were transfected with
plasmids expressing either caspase-7 (C7 PL) or the red fluorescent
protein (RFP PL) using Superfect (SF) or Amaxa (Ax), then cell
lysates were analyzed by western blots with anti-caspase-7
antibodies. (B) Casp-7
2/2 macrophages transfected or not with
C7 plasmid or RFP by SF were infected with L. pneumophila and
colony forming units were quantified at designated time points.
The results represent the mean of three independent experiments
6SD.
Found at: doi:10.1371/journal.ppat.1000361.s004 (0.04 MB PDF)
Figure S5 Differential trafficking of L. pneumophila in caspase-
7
2/2 macrophages requires a functional type IV secretion system.
(A) Wild-type C57BL/6 (B6), caspase-7
2/2 (casp-7
2/2), and
caspase-1
2/2 (casp-1
2/2) macrophages were seeded on cover slips
and infected with the Dot/Icm type IV secretion mutant for 2 hrs
and bacteria were examined for co-localization with LAMP-1. (B)
B6 macrophages seeded over cover slips were infected with wild-
type L. pneumophila then the organism and its degradation
fragments were detected with anti-Legionella antibody and
secondary fluorescent antibody. *, P value#0.05. The results
represent the mean of three independent experiments 6SD.
Found at: doi:10.1371/journal.ppat.1000361.s005 (0.01 MB PDF)
Figure S6 IL-1b and IL-18 do not affect caspase-7 activation or
L. pneumophila infection. (A) Wild-type C57BL/6 (B6) and IL-1b
2/2
/IL-18
2/2 derived macrophages were not treated (No treat) or
infected with wild-type L. pneumophila (Leg) or flagellin mutant (Fla)
then cell lysates were analysed by western blots with ani-caspase-7
antibodies. (B) B6, IL-1b
2/2/IL-18
2/2, Caspase-7
2/2 (casp-7
2/2),
and A/J-derived (Naip5
AJ) macrophages were infected with wild-
typeL.pneumophilaandcolonyformingunits(CFU)wererecoveredat
designated time points. (C) B6 and casp-7
2/2 macrophages were
infected with L. pneumophila in the presence or absence of exogenous
recombinant (r) IL-1b,r I L - 1 8 ,I L - 1 b receptor (R) antibody (AB), or
IL-18 R AB, then CFUs were scored at indicated time points. Data
represent the mean of three independent experiments 6SD.
Found at: doi:10.1371/journal.ppat.1000361.s006 (0.03 MB PDF)
Figure S7 Caspase-7 does not regulate cytokine secretion in
macrophages. (A) Macrophages from wild-type C57BL/6 (B6),
caspase-1
2/2 (casp-1
2/2), or caspase-7
2/2 (casp-7
2/2) mice were
not infected (white bars) or infected (black bars) with L. pneumophila
(A) or Salmonella typhimurium (Salmonella) (B), then cell supernatants
were examined for IL-1b release. Data represent the mean of three
independent experiments 6SD. *, P value#0.05.
Found at: doi:10.1371/journal.ppat.1000361.s007 (0.05 MB PDF)
Figure S8 L. pneumophila induces mild pulmonary apoptosis in
wild-type mice and in mice lacking caspase-7, -1, or wild-type
Naip5. (A) Lungs from infected wild-type C57BL/6, caspase-1
2/2,
caspase-7
2/2, and A/J mice were harvested at 72 hrs post infection
and stained for TUNEL to detect apoptotic nuclei. (B) TUNEL-
positive stained cells (brown) were evaluated by capturing digital
images and the percent of brown pixels per high powered field were
quantified. Data represent the mean of at least 32 images per lung
6SD.
Found at: doi:10.1371/journal.ppat.1000361.s008 (0.09 MB PDF)
Figure S9 Human monocytes do not activate caspase-1 or
caspase-7 in response to L. pneumophila infection. Fresh human
monocytes were infected or not (No treat) with L. pneumophila (Leg)
or Salmonella at an MOI of 0.5 for 2 hrs. Then, cell lysates were
analyzed by western blots using anti-caspase-1 (A) and -caspase-7
(B) antibodies. Data are representative of three experiments from
three independent donors.
Found at: doi:10.1371/journal.ppat.1000361.s009 (0.06 MB PDF)
Table S1 L. pneumophila replicates in the absence of caspase-7
activation in Nlrc4
2/2, caspase-1
2/2 (casp-1
2/2), caspase-7
2/2
(casp-7
2/2), and in A/J (Naip5
AJ) macrophages. Caspase-7
activation restricts L. pneumophila replication in C57BL/6 (B6)
and in IL-1b
2/2/IL-18
2/2 macrophages.
Found at: doi:10.1371/journal.ppat.1000361.s010 (0.02 MB PDF)
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